+ Watch SENO
on My Watchlist
The Company develops, manufactures and sells minimally-invasive medical devices for the diagnosis of breast cancer.
Company is overvalued in terms of fundamental prospects (source Ultralong).
Great startup will do well. Very good business lan in a much needed area with outstanding products
It's already outeperformed S & P once.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions